Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study

Valenti, Luca; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Bugianesi, Elisabetta; Marchesini, Giulio; Manzini, Paola; Vanni, Ester; Fargion, Silvia
June 2007
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1251
Academic Journal
OBJECTIVES: Hyperferritinemia is frequently observed in nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome characterized by hepatic insulin resistance and considered high cardiovascular risk. Iron depletion by phlebotomy has been reported to decrease insulin resistance in NAFLD in small, uncontrolled studies. Aims of this study were to define the relationship between ferritin and iron stores in patients with NAFLD, the effect of iron depletion on insulin resistance, and whether basal ferritin levels influence treatment outcome. METHODS: Subjects were included if ferritin and/or ALT were persistently elevated after 4 months of standard therapy. Sixty-four phlebotomized subjects were matched 1:1 for age, sex, ferritin, obesity, and ALT levels with patients who underwent lifestyle modifications only. Insulin resistance was evaluated by insulin levels, determined by RIA and the HOMA-R index, at baseline and after 8 months. RESULTS: Baseline ferritin levels were associated with body iron stores ( P < 0.0001). Iron depletion produced a significantly larger decrease in insulin resistance ( P= 0.0016 for insulin, P= 0.0042 for HOMA-R) compared with nutritional counseling alone, independent of changes in BMI, baseline HOMA-R, and the presence of the metabolic syndrome. Iron depletion was more effective in reducing HOMA-R in patients in the top two tertiles of ferritin concentrations ( P < 0.05 vs controls), and in carriers of the mutations in the HFE gene of hereditary hemochromatosis ( P < 0.05 vs noncarriers). CONCLUSIONS: Given that phlebotomy reduces insulin resistance, which is associated with liver tissue damage, future studies should evaluate the effect of iron depletion on liver histology and cardiovascular end points.


Related Articles

  • Hereditary Hemochromatosis – A New Look at an Old Disease. Pietrangelo, Antonello // New England Journal of Medicine;6/3/2004, Vol. 350 Issue 23, p2383 

    The article discusses some of the important features of classic HFE-related hereditary hemochromatosis features that are shared by other phenotypic forms of hereditary hemochromatosis. Classic hereditary hemochromatosis is an autosomal recessive iron-overload disorder associated with mutation of...

  • Esteatosis hepática, esteatohepatitis y marcadores de lesión hepática. Barba Evia, José Roberto // Revista Mexicana de Patologia Clinica;oct-dic2008, Vol. 55 Issue 4, p216 

    Nonalcohlic fatty liver disease affects a large proportion of the population. Is a clinicopathological entity characterized by the development of histological changes in the liver that are nearly identical to those induced by excessive alcohol intake, but in the absence of intake of this....

  • The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Qing Liu; Stig Bengmark; Shen Qu // Lipids in Health & Disease;2010, Vol. 9, p42 

    Nonalcoholic fatty liver disease is increasingly regarded as a hepatic manifestation of metabolic syndrome, and the severity of nonalcoholic fatty liver disease seems to increase in parallel with other features of metabolic syndrome. Excess lipid accumulation in the liver cells is not only a...

  • Non-alcoholic fatty liver disease and the metabolic syndrome: An update. Rector, R. Scott; Thyfault, John P.; Yongzhong Wei; Ibdah, Jamal A. // World Journal of Gastroenterology;1/14/2008, Vol. 14 Issue 2, p185 

    Sedentary lifestyle and poor dietary choices are leading to a weight gain epidemic in westernized countries, subsequently increasing the risk for developing the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD). NAFLD is estimated to affect approximate 30% of the general US...

  • The Fatty Liver and Insulin Resistance. Yki-Järvinen, H.; Westerbacka, J. // Current Molecular Medicine;May2005, Vol. 5 Issue 3, p287 

    Obesity is not necessary to observe insulin resistance in humans since severe insulin resistance also characterizes patients lacking subcutaneous fat such as those with HAART (highlyactive antiretroviral therapy) - associated lipodystrophy. Both the obese and the lipodystrophic patients have,...

  • Diabetes and Nonalcoholic Fatty Liver Disease. Kantartzis, Konstantinos; Gastaldelli, Amalia; Magkos, Faidon; Lavoie, Jean-Marc // Experimental Diabetes Research;2012, Special section p1 

    The article discusses papers within the January 2012 issue of "Experimental Diabetes Research," including a paper on diagnosis and evaluation of nonalcoholic fatty liver disease, a paper on the role of transcription factor modifications in the pathogenesis of insulin resistance, and a paper on...

  • The blind men 'see' the elephant-the many faces of fatty liver disease. Sanal, Madhusudana Girija; Hübscher, Stefan G. // World Journal of Gastroenterology;2/14/2008, Vol. 14 Issue 6, p831 

    Nonalcoholic fatty liver disease (NAFLD) is a group of diseases with excess fat in liver in the absence of a poorly defined limit of alcohol consumption. Most common variety, a universal public health problem, is associated with insulin resistance caused by a host of genetic and epigenetic...

  • Pathogenesis of non-alcoholic fatty liver disease. DOWMAN, J. K.; TOMLINSON, J. W.; NEWSOME, P. N. // QJM: An International Journal of Medicine;Feb2010, Vol. 103 Issue 2, p71 

    The article discusses the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Although this disease can be experienced by all ethnic groups, there seems to have a lower prevalence rate in African Americans when compared to Hispanic and European Americans. NAFLD is often linked to features...

  • Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis. Valenti, Luca; Rametta, Raffaela; Dongiovanni, Paola; Maggioni, Marco; Fracanzani, Anna Ludovica; Zappa, Marco; Lattuada, Enzo; Roviaro, Giancarlo; Fargion, Silvia // Diabetes;May2008, Vol. 57 Issue 5, p1355 

    OBJECTIVE--Nonalcoholic fatty liver, affecting 34% of the U.S. population, is characterized by hepatic insulin resistance, which is more marked in the presence of steatohepatitis, and frequently precedes hyperglycemia. The molecular mechanisms underlying the relationship between fatty liver and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics